Bibliography
- SNIDER GLL, KLEINERMAN WM, THURLBECK WM, BENGALI ZH: The definition of emphysema: report of a National, Heart, Lung and Blood Institute Division of Lung Diseases Workshop. Am. Rev. Respir. Dis. (1985) 132:182-185.
- REYNOLDS CP, MAURER BJ, KOLESNICH RN: Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett. (2004) 206:169-180.
- KASAHARA Y, TUDER RM, COOL CD et al.: Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am. J. Respir. Crit. Care Med. (2001) 163:737-744.
- KASAHARA Y, TUDER RM, TARASEVICIENE-STEWART L et al.: Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J. Clin. Invest. (2000) 106:1311-1319.
- TUDER RM, ZHEN L, CHO CY et al.: Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am. J. Respir. Cell Mol. Biol. (2003) 29:88-97.
- PETRACHE I, NATARAJAN V, ZHEN L et al.: Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat. Med. (2005) 11:491-498.
- MOLET S, BELLEGUIC C, LENA H et al.: Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease. Inflamm. Res. (2005) 54:31-36.
- GRONEBERG DA, CHUNG KF: Models of chronic obstructive pulmonary disease. Respir. Res. (2004) 5(1):18.
- RILEY RT, EVONGENE E, VOSS VA et al.: Sphingoloid perturbations as mechanisms for fumonisin carcinogenesis. Environ. Health Perspect. (2001) 109(Suppl. 2):301-308.
- JOHNSON VJ, HE Q, OSUCHOWSKI MF, SHARMA RP: Disruption of sphingolipid homeostasis by myriocin, a mycotoxin, reduces thymic and splenic T-lymphocyte populations. Toxiciology (2004) 201:67-75.
- LESTUNFF H, GALVE-ROPERH I, PETERSON C, MILSTEIN S, SPIEGEL S: Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis. J. Cell Biol. (2002) 158:1039-1049.